JVMTX
Price
$30.35
Change
-$0.19 (-0.62%)
Updated
Sep 20 closing price
VMFVX
Price
$381.31
Change
-$3.11 (-0.81%)
Updated
Sep 20 closing price
Ad is loading...

JVMTX vs VMFVX

Header iconJVMTX vs VMFVX Comparison
Open Charts JVMTX vs VMFVXBanner chart's image
JHancock Disciplined Value Mid Cap R4
Price$30.35
Change-$0.19 (-0.62%)
VolumeN/A
CapitalizationN/A
Vanguard S&P Mid-Cap 400 Value Idx I
Price$381.31
Change-$3.11 (-0.81%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JVMTX vs VMFVX Comparison Chart
Loading...
VS
JVMTX vs. VMFVX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMTX is a Buy and VMFVX is a Buy.

FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 23.4B vs. VMFVX (1.04B). VMFVX pays higher dividends than JVMTX: VMFVX (1.53) vs JVMTX (0.73). JVMTX was incepted earlier than VMFVX: JVMTX (11 years) vs VMFVX (14 years). VMFVX (43.00) and JVMTX (41.00) have comparable annual turnover. JVMTX has a lower initial minimum investment than VMFVX: JVMTX (0) vs VMFVX (5000000). VMFVX annual gain was more profitable for investors over the last year : 22.09 vs. JVMTX (19.27). VMFVX return over 5 years is better than : 56.33 vs. JVMTX (43.64).
JVMTXVMFVXJVMTX / VMFVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years14 years-
Gain YTD11.0109.058122%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.4B1.04B2,244%
Annual Yield % from dividends0.731.5348%
Returns for 1 year19.2722.0987%
Returns for 3 years13.3822.4260%
Returns for 5 years43.6456.3377%
Returns for 10 years63.34112.6956%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVR0.78-0.01
-0.85%
AlloVir
LEA108.02-2.00
-1.82%
Lear Corp
RWAY10.13-0.24
-2.31%
Runway Growth Finance Corp
SLNO51.50-1.23
-2.33%
Soleno Therapeutics
TIVC0.27-0.01
-3.57%
Tivic Health Systems